12:00 AM
Jul 22, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Kamada preclinical data

In mice, single-dose anti-CD4/ CD8 treatment plus Glassia significantly delayed time to graft rejection and increased the rate of graft acceptance of rat to mouse pancreatic islet xenograft transplantation vs. anti-CD4/CD8 treatment alone. Data were published in PloS ONE. The study was conducted...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >